CD44, one of the main Wnt/beta-catenin signaling target molecules as well as cancer stem cell marker molecules [39, 40], is involved in acquisition of resistance to oxidative stress induced by the action of chemotherapeutic agents on the xCT transporter [40, 41]. This evidence concerns the gene CD44 and cancer.